{{chembox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 449587261
| ImageFile=Setoperone.svg
| ImageSize=250px
| IUPACName=6-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-7-methyl-2,3-dihydro-[1,3]thiazolo[3,2-a]pyrimidin-5-one
| OtherNames=

|Section1={{Chembox Identifiers
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = BQ67CS3Q3E
| CASNo_Ref = {{cascite|correct|??}}
| CASNo=86487-64-1
| PubChem=68604
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02686
| SMILES=CC1=C(C(=O)N2CCSC2=N1)CCN3CCC(CC3)C(=O)C4=CC=C(C=C4)F
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 61870
| InChI = 1/C21H24FN3O2S/c1-14-18(20(27)25-12-13-28-21(25)23-14)8-11-24-9-6-16(7-10-24)19(26)15-2-4-17(22)5-3-15/h2-5,16H,6-13H2,1H3
| InChIKey = RBGAHDDQSRBDOG-UHFFFAOYAH
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C21H24FN3O2S/c1-14-18(20(27)25-12-13-28-21(25)23-14)8-11-24-9-6-16(7-10-24)19(26)15-2-4-17(22)5-3-15/h2-5,16H,6-13H2,1H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = RBGAHDDQSRBDOG-UHFFFAOYSA-N
  }}

|Section2={{Chembox Properties
| Formula=C<sub>21</sub>H<sub>24</sub>FN<sub>3</sub>O<sub>2</sub>S
| MolarMass=401.50 g/mol
| Appearance=
| Density=
| MeltingPt=
| BoilingPt=
| Solubility=
  }}

|Section3={{Chembox Hazards
| MainHazards=
| FlashPt=
| AutoignitionPt =
  }}
}}

'''Setoperone''' is a compound that is a [[ligand]] to the [[5-HT2A receptor|5-HT<sub>2A</sub> receptor]].
It can be radiolabeled with the [[radioisotope]] [[fluorine-18]] and used as a [[radioligand]] with [[positron emission tomography]] (PET).
Several research studies have used the radiolabeled setoperone in [[neuroimaging]]  for the studying [[neuropsychiatric disorder]]s, such as [[depression (mood)|depression]]<ref>{{Cite journal
| author = [[Jeffrey H. Meyer]], Shitij Kapur, [[Sylvain Houle]], Jean DaSilva, Beata Owczarek, Gregory M. Brown, Alan A. Wilson and Sidney H. Kennedy
| title = Prefrontal Cortex 5-HT2 Receptors in Depression: An &#91;<sup>18</sup>F&#93;Setoperone PET Imaging Study
| journal = [[American Journal of Psychiatry]]
| volume = 156
| pages = 1029–1034
| url = http://ajp.psychiatryonline.org/cgi/content/full/156/7/1029
| pmid = 10401447
| issue = 7
| date = July 1, 1999 | doi = 10.1176/ajp.156.7.1029
| doi-broken-date = 2017-08-13
}}</ref>
or [[schizophrenia]].<ref>{{Cite journal
| author = Ralph Lewis, Shitij Kapur, Corey Jones, Jean DaSilva, Gregory M. Brown, Alan A. Wilson, [[Sylvain Houle]] and Robert B. Zipursky
| title = Serotonin 5-HT<sub>2</sub> Receptors in Schizophrenia: A PET Study Using &#91;<sup>18</sup>F&#93;Setoperone in Neuroleptic-Naive Patients and Normal Subjects
| journal = [[American Journal of Psychiatry]]
| volume = 156
| pages = 72–78
| url = http://ajp.psychiatryonline.org/cgi/content/abstract/156/1/72
| pmid = 9892300
| issue = 1
| date = January 1, 1999 | doi = 10.1176/ajp.156.1.72
}}</ref>

==References==
{{Reflist}}

{{Antipsychotics}}

[[Category:5-HT2A antagonists]]
[[Category:Abandoned drugs]]
[[Category:Aromatic ketones]]
[[Category:Fluoroarenes]]
[[Category:Piperidines]]
[[Category:Receptor modulators]]
[[Category:Thiazolopyrimidines]]

{{nervous-system-drug-stub}}